RECRUITINGOBSERVATIONAL

Assesment and Comparison of Osteoporosis Risk Factors After Stroke

Comparison of Osteoporosis Risk in the Subacute and Chronic Periods Following Stroke and Evaluation of Factors Increasing Osteoporosis

About This Trial

The aim of this study is to evaluate the effect of these factors and stroke itself on osteoporosis developing after stroke. Thus, the expected benefit of the study is to contribute to the identification and determination of the need for treatment in high-risk patients through further studies. There are no expected risks from the study.

Who May Be Eligible (Plain English)

Who May Qualify: 1. Followed by ischemic or hemorrhagic stroke 2. Between 1 week and 6 months or \>1 year has passed since the date of the event 3. Being between 55 and 85 years of age Who Should NOT Join This Trial: 1. The patient has additional neurological conditions besides stroke 2. The patient has a psychiatric condition 3. History of recurrent stroke 4. BMD scan performed within the last year for stroke patients 5. Having received osteoporosis treatment before or after the stroke 6. The patient having a fragility fracture before the stroke 7. The patient having a hip fracture or hip prosthesis 8. The patient having an additional condition that affects physical function before the stroke (amputation, severe fracture) 9. The patient has an additional disease or medication use that could cause secondary osteoporosis 10. The patient's stroke did not cause physical function loss Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language

Inclusion Criteria: 1. Followed by ischemic or hemorrhagic stroke 2. Between 1 week and 6 months or \>1 year has passed since the date of the event 3. Being between 55 and 85 years of age Exclusion Criteria: 1. The patient has additional neurological conditions besides stroke 2. The patient has a psychiatric condition 3. History of recurrent stroke 4. BMD scan performed within the last year for stroke patients 5. Having received osteoporosis treatment before or after the stroke 6. The patient having a fragility fracture before the stroke 7. The patient having a hip fracture or hip prosthesis 8. The patient having an additional condition that affects physical function before the stroke (amputation, severe fracture) 9. The patient has an additional disease or medication use that could cause secondary osteoporosis 10. The patient's stroke did not cause physical function loss

Treatments Being Tested

DIAGNOSTIC_TEST

Bone Mineral Density

Patients who have had a stroke and are at risk of fracture, and for whom routine assessment requires Bone Mineral Density (BMD) testing, will be included in the study. In addition, patients who have already undergone BMD testing for osteoporosis screening and who present to the outpatient clinic, with similar age and comorbidities, will be screened from the system, and 28 non-stroke patients who agree to participate will be included in the study.

Locations (1)

Ankara Etlik City Hospital

Ankara, Yenimahalle, Turkey (Türkiye)